UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021531
Receipt number R000024769
Scientific Title A study on safety of risk reducing mastectomy(RRM)
Date of disclosure of the study information 2016/03/24
Last modified on 2019/04/25 14:04:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on safety of risk reducing mastectomy(RRM)

Acronym

A study on safety of RRM

Scientific Title

A study on safety of risk reducing mastectomy(RRM)

Scientific Title:Acronym

A study on safety of RRM

Region

Japan


Condition

Condition

Hereditary breast and ovarian cancer

Classification by specialty

Breast surgery Obstetrics and Gynecology Plastic surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To confirm the safety of risk reducing mastectomy

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Adverse event related to RRM during 3 months after RRM

Key secondary outcomes

Adverse event related to RRM between 3 months and 5 years after RRM


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

risk reducing mastectomy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.BRCA1/2 mutation carriers
2.Woman with breast cancer in present or
the past
3.Woman who received genetic counseling
4.ECOG Performance Status=0
5.Informed consent

Key exclusion criteria

1.Woman with unstable mental state
2.Pregnant or lactating woman
3.Woman with active overlap cancer
4.The case in which doctor does not
approve to perform RRM.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akiyo Yoshimura

Organization

Aichi Cancer Center Hospital

Division name

breast oncology

Zip code


Address

1-1.Kanokoden,Chikusa-ku,Nagoya

TEL

052-762-6111

Email

akiyo@aichi-cc.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akiyo Yoshimura

Organization

Aichi Cancer Center Hospital

Division name

breast oncology

Zip code


Address

1-1.Kanokoden,Chikusa-ku,Nagoya

TEL

052-762-6111

Homepage URL


Email

akiyo@aichi-cc.jp


Sponsor or person

Institute

Aichi Cancer Center Hospital

Institute

Department

Personal name



Funding Source

Organization

Aichi Cancer Center Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知県がんセンター中央病院 (Aichi Cancer Center Hospital) 


Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 24 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2014 Year 04 Month 15 Day

Date of IRB

2014 Year 02 Month 21 Day

Anticipated trial start date

2014 Year 04 Month 24 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 03 Month 18 Day

Last modified on

2019 Year 04 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024769


Research Plan
Registered date File name
2017/03/20 研究実施計画書 .doc

Research case data specifications
Registered date File name

Research case data
Registered date File name